272
REFERENCIAS BIBLIOGRÁFICAS
1. Szot J. Mortalidad por infarto agudo al miocardio en Chile: 1990–
2001. Rev Med Chil. 2004;132(10):1227–33.
2. Medina E, Kaempffer AM. Mortalidad por cáncer en
Chile: consideraciones epidemiológicas. Rev Med Chil.
2001;129(10):1195–202.
3. Medina E, Kaempffer AM. Mortalidad del adulto en Chile. Rev Med
Chil. 2000;128(10): 1144–9.
4. Albala C, Vio F, Robledo A, Icaza G. La transición epidemiológica en
Chile. Rev Med Chil. 1993;121(12):1446–55.
5. Ministerio de Salud, Chile. Mortalidad por causas. Santiago, Chile:
Ministerio de Salud;2009. Hallado en:
http://deis.minsal.cl/deis/ind_2007.asp. Acceso el 22 de noviembre de 2010.
6. Estrategia nacional de salud para el cumplimiento de los objetivos
sanitarios de la década 2011-2020.Gobierno de Chile. MINSAL
2010.
7. Alonso F, et al. Mortalidad por Enfermedad Isquémica en Chile:
Cuántos y Dónde. Rev Chilena de Cardiología 2009;28:391.
8. Gobierno de Chile. Ministerio de Salud. Estudio de carga
enfermedad 2007.
9. Barbash IM, Freimark D. Outcome of myocardial infarction
in patients treated with aspirin is enhanced by pre-hospital
administration. Cardiology. 2002;98(3):141-7).
10. Quan D, LoVecchio F, Clark B, Gallagher JV: Prehospital use of
aspirin rarely is associated with adverse events. Prehosp Disast
Med 2004; 19(4):362–365).
11. Ministerio de Salud. Guía clínica infarto agudo del miocardio con
supradesnivel del segmento st. Santiago: Minsal, 2010
12. Peter J. Zimetbaum, M.D., and Mark E. Josephson, M.D. Use of the
Electrocardiogram in Acute Myocardial Infarction. N Engl J Med
2003;348:933-40.
13. Victor F Froelicher. Review: important bedside predictors are
patient’s description of chest pain for CAD and electrocardiography
for MI. Evid. Based Med. 2005;10;54.
14. Henry H. Ting, MD, MBA, Chair; Harlan M. Krumholz, MD.
Implementation and Integration of Prehospital ECGs Into
Systems of Care for Acute Coronary Syndrome. Circulation
2008;118;1066-1079.
15. Curtis JP, Portnay EL. The pre-hospital electrocardiogram and
time to reperfusion in patients with acute myocardial infarction,
2000-2002: findings from the National Registry of Myocardial
Infarction-4. J Am Coll Cardiol. 2006 Apr 18;47(8):1544-52.
Epub 2006 Mar 29.
16. Karagounis L, Ipsen SK, Jessop MR, Gilmore KM, Valenti DA,
Clawson JJ, et al. Impact of field-transmitted electrocardiography
on time to in-hospital thrombolytic therapy in acute myocardial
infarction. Am J Cardiol. 1990;66:786 –791.
17. Foster DB, Dufendach JH, Barkdoll CM, Mitchell BK. Prehospital
recognition of AMI using independent nurse/paramedic 12-lead
ECG evaluation: impact on in-hospital times to thrombolysis in a
rural community hospital. Am J Emerg Med. 1994;12:25–31.
18. Whitbread M, Leah V, Bell T, Coats TJ. Recognition of ST elevation
by paramedics. Emerg Med J. 2002;19:66–67.
19. Dhruva VN, Abdelhadi SI, Anis A, Gluckman W, Hom D, Dougan
W, et al. ST-Segment Analysis Using Wireless Technology in
Acute Myocardial Infarction (STAT-MI) trial. J Am Coll Cardiol.
2007;50:509 –513.
20. Robert E. O’Connor, William Brady, Steven C. Brooks, Deborah
Diercks, Jonathan Egan, Chris Ghaemmaghami, et al. Travers
and Demetris Yannopoulos Part 10: Acute Coronary Syndromes:
2010 American Heart Association Guidelines for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care. Circulation
2010;122;S787-S817.
21. Prehospital thrombolytic therapy in patients with suspected acute
myocardia infarction. The European Myocardial Infarction Project
Group. N Engl J Med. 1993;329:383–389).
22. Ulf Stenestrand, Johan Lindback. Long-term Outcome of Primary
Percutaneous Coronary Intervention vs Prehospital and In-Hospital
Thrombolysis for Patients With ST-Elevation Myocardial Infarction.
JAMA, October 11, 2006—Vol 296, No. 14).
23. Feasibility, safety, and efficacy of domiciliary thrombolysis by
general practitioners: Grampian region early anistreplase trial.
GREAT Group. BMJ. 1992;305(6853):548 –553).
24. McCaul M, Lourens A, Kredo T. Pre-hospital versus in-hospital
thrombolysis for ST-elevation myocardial infarction. Cochrane
Database of Systematic Reviews 2014, Issue 9. Art. No.:
CD010191. DOI: 10.1002/14651858.CD010191.pub2.
25. Laurie J. Morrison, MD. Mortality and Prehospital Thrombolysis for
Acute Myocardial Infarction . A Meta-analysis. JAMA, May 24/31,
2000—Vol 283, No. 20.
26. Sørensen JT, Terkelsen CJ, Stengaard C, Lassen JF, Trautner S,
ChristensenEF, et al. Prehospital troponin T testing in the diagnosis
and triage of patients with suspected acute myocardial infarction.
Am J Cardiol 2011;107:1436e1440.
27. Schuchert A, HammC, Scholz J, Klimmeck S, Goldmann B, Meinertz
T. Prehospital testing for troponin T in patients with suspected
acute myocardial infarction. Am Heart J 1999;138:45e48.
28. Svensson L, Axelsson C, Nordlander R, Herlitz J. Elevation of
biochemical markers for myocardial damage prior to hospital
admission in patients with acute chest pain or other symptoms
raising suspicion of acute coronary syndrome. J Intern Med
2003;253:311e319.
29. Stengaard, Carsten et al. Quantitative Point-of-Care Troponin
T Measurement for Diagnosis and Prognosis in Patients With
a Suspected Acute Myocardial Infarction. Am J. of Cardiology ,
Volume 112 , Issue 9 , 1361 – 1366.
El autor declara no tener conflictos de interés, en relación a este artículo.
[REV. MED. CLIN. CONDES - 2017; 28(2) 267-272]